- £193.88m
- £167.93m
- £110.67m
- 91
- 45
- 86
- 91
Annual balance sheet for Science, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 29.1 | 37.2 | 46.5 | 32.8 | 41.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10.9 | 12.2 | 12.8 | 23.2 | 26.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 42.7 | 53.3 | 64 | 59.3 | 73 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23.8 | 23.4 | 23.9 | 25.9 | 25 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 92 | 116 | 127 | 133 | 141 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 29.9 | 33.8 | 34.6 | 35.7 | 39.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 50.7 | 49.6 | 49.1 | 54.5 | 57.1 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 41.4 | 66.3 | 78.2 | 78.4 | 84 |
Total Liabilities & Shareholders' Equity | 92 | 116 | 127 | 133 | 141 |
Total Common Shares Outstanding |